ANDRE-JACQUES AUBERTON-HERVE

Insider Reports History

Location
La Tronche, France
Signature
/s/ Andre-Jacques Auberton-Herve
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ANDRE-JACQUES AUBERTON-HERVE:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Chavant Capital Acquisition Corp. Director Class A Common Stock 541K $5.41M $10.00 21 Dec 2023 Indirect
Bionik Laboratories Corp. Director Common Stock 1.11M $666K $0.60 13 Jun 2023 Shares held through Star SCI
Chavant Capital Acquisition Corp. Director Class A Common Stock 27.8K $278K $10.00 21 Dec 2023 Direct
Bionik Laboratories Corp. Director Common Stock 95.1K $57.1K $0.60 13 Jun 2023 Direct
Bionik Laboratories Corp. Director Common Stock 10.7K $6.42K $0.60 13 Jun 2023 Shares held through 4A Consulting and Engineering
Chavant Capital Acquisition Corp. Director Make-Whole Shares (right to acquire) 145K 21 Dec 2023 Indirect
Bionik Laboratories Corp. Director Convertible Promissory Note 1 13 Jun 2023 Through Star SCI
Bionik Laboratories Corp. Director Stock Option (right to buy) 0 15 Jul 2021 Direct

Insider Reports Filed by ANDRE-JACQUES AUBERTON-HERVE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MOBX Chavant Capital Acquisition Corp. 21 Dec 2023 3 $1.45M 4 Director 26 Dec 2023, 17:56
BNKL Bionik Laboratories Corp. 13 Jun 2023 2 $332K 4 Director 21 Jun 2023, 10:58
BNKL Bionik Laboratories Corp. 09 Jun 2023 1 $390K 4 Director 21 Jun 2023, 10:55
CLAY Chavant Capital Acquisition Corp. 24 Feb 2022 1 $0 4 Director 28 Feb 2022, 10:38
CLAY Chavant Capital Acquisition Corp. 19 Jul 2021 0 $0 3 Director 20 Jul 2021, 18:19
BNKL Bionik Laboratories Corp. 15 Jul 2021 4 $210K 4 Director 21 Jun 2022, 17:49